Events

Online session about Social Science and Humanities (SSH) in Cluster 6 by CARE4BIO
OCT
Mon
28
14:30 - 15:30

This was 1 year ago

Location

Online

Programmes
Agro-Food, Environment

CARE4BIO in collaboration with Net4Society will provide an online informative session to share insights and details on the SSH theme in Horizon Europe, with a special focus on cluster 6.

This session aims to produce meaningful effects that enhance the societal impact of related research/innovation activities.

The event will offer information on:

  • which kind of contribution the SSH experts can bring in the proposals
  • how to create an effective collaboration in the interdisciplinary team
  • practical examples and tips to build up a successful collaboration

This session will be streamed on the CARE4BIO YouTube channel. Access it here.

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.